AXIM Biotechnologies Statistics
Total Valuation
AXIM has a market cap or net worth of 2.31 million. The enterprise value is 9.09 million.
| Market Cap | 2.31M |
| Enterprise Value | 9.09M |
Important Dates
The last earnings date was Monday, May 19, 2025.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AXIM has 355.63 million shares outstanding.
| Current Share Class | 355.63M |
| Shares Outstanding | 355.63M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +10.53% |
| Owned by Insiders (%) | 12.90% |
| Owned by Institutions (%) | n/a |
| Float | 287.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.88 |
| PB Ratio | -0.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.20 |
| EV / Sales | 97.83 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.93 |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -8.90 |
| Interest Coverage | -2.96 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -36.27% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 81.33% |
| Revenue Per Employee | 13,271 |
| Profits Per Employee | -590,839 |
| Employee Count | 7 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.38% in the last 52 weeks. The beta is 0.06, so AXIM's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | -56.38% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 46.73 |
| Average Volume (20 Days) | 149,006 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.18 |
Income Statement
In the last 12 months, AXIM had revenue of 92,898 and -4.14 million in losses. Loss per share was -0.02.
| Revenue | 92,898 |
| Gross Profit | 91,154 |
| Operating Income | -2.31M |
| Pretax Income | -4.14M |
| Net Income | -4.14M |
| EBITDA | -1.88M |
| EBIT | -2.31M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 6,044 in cash and 6.78 million in debt, giving a net cash position of -6.78 million or -0.02 per share.
| Cash & Cash Equivalents | 6,044 |
| Total Debt | 6.78M |
| Net Cash | -6.78M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -9.53M |
| Book Value Per Share | -0.03 |
| Working Capital | -6.55M |
Cash Flow
In the last 12 months, operating cash flow was -758,995 and capital expenditures -2,839, giving a free cash flow of -761,834.
| Operating Cash Flow | -758,995 |
| Capital Expenditures | -2,839 |
| Free Cash Flow | -761,834 |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 98.12% |
| Operating Margin | -2,490.35% |
| Pretax Margin | -4,452.06% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AXIM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.42% |
| Shareholder Yield | n/a |
| Earnings Yield | -178.92% |
| FCF Yield | -32.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AXIM has an Altman Z-Score of -32 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -32 |
| Piotroski F-Score | 2 |